ABC | Volume 114, Nº3, Março 2020

Artigo Original Kurmus et al. Discordância entre lipoproteínas e gravidade da DAC Arq Bras Cardiol. 2020; 114(3):469-475 Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons 14. Boekholdt SM, Arsenault BJ, Mora S, Pedersen TR, LaRosa JC, Nestel PJ, et al. Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis. JAMA. 2012;307(12):1302-9. 15. Varbo A, Benn M, Tybjærg-Hansen A, Jørgensen AB, Frikke-Schmidt R, Nordestgaard BG. Remnant cholesterol as a causal risk factor for ischemic heart disease. J Am Coll Cardiol. 2013;61(4):427-36. 16. Bittencourt MS, Santos RD, Staniak H, Sharovsky R, Kondapally R, Vallejo- Vaz AJ , et al. Relation of fasting triglyceride rich lipoprotein cholesterol to coronary artery calcium score (from the ELSA-Brasil Study). Am J Cardiol. 2017;119(9):1352-58. 17. Sniderman A, McQueen M, Contois J , Williams K, Furberg CD . Why is non-high-density lipoprotein cholesterol a better marker of the risk of vascular disease than low-density lipoprotein cholesterol? J Clin Lipidol. 2010;4(3):152-5. 18. Otvos JD, Mora S, Shalaurova I, Greenland P, Mackey RH, Goff DC Jr. Clinical implications of discordance between low-density lipoprotein cholesterol and particle number. J Clin Lipidol. 2011;5(2):105-13. 19. Cromwell WC, Otvos JD, Keyes MJ, Pencina MJ, Sullivan L, Vasan RS, et al. LDL particle number and risk of future cardiovascular disease in the Framingham Offspring Study - Implications for LDL management. J Clin Lipidol. 2007;1(6):583-92. 20. SnidermanAD , St-PierreAC, CantinB, DagenaisGR, Després JP , LamarcheB. Concordance/discordance between plasma apolipoprotein B levels and the cholesterol indexesofatheroscleroticrisk.AmJCardiol.2003;91(10):1173-7. 21. Sniderman AD, Islam S, Yusuf S, McQueen MJ. Discordance analysis of apolipoprotein B and non-high density lipoprotein cholesterol as markers of cardiovascular risk in the INTERHEART study. Atherosclerosis. 2012;225(2):444-9. 22. Sniderman AD, IslamS, Yusuf S, McQueenMJ . Is the superiority of apoB over non-HDL-C as amarker of cardiovascular risk in the INTERHEART study due to confounding by related variables? J Clin Lipidol. 2013;7(6):626-31. 23. Sniderman AD, Lamarche B, Contois JH, de Graaf J . Discordance analysis and the Gordian Knot of LDL and non-HDL cholesterol versus apoB. Curr Opin Lipidol. 2014;25(6):461-7. 24. Elshazly MB, Martin SS, Blaha MJ, Joshi PH, Toth PP , McEvoy JW, et al. Non-high-density lipoprotein cholesterol, guideline targets, and population percentiles for secondary prevention in 1.3 million adults: the VLDL-2 study (very large database of lipids). J Am Coll Cardiol. 2013;62(21):1960-5. 25. AbateN, VegaGL, Grundy SM. Variability in cholesterol content and physical properties of lipoproteins containing apolipoprotein B-100. Atherosclerosis. 1993;104(1-2):159-71. 26. Kuwabara K, Harada S, Sugiyama D, Kurihara A, Kubota Y, Higashiyama A, et al. Relationship between non-high-density lipoprotein cholesterol and low-density lipoprotein cholesterol in the general population. J Atheroscler Thromb. 2016;23(4):477-90. 27. Budde T , Fechtrup C, Bösenberg E, Vielhauer C , Enbergs A, Schulte H, et al. Plasma Lp(a) levels correlate with number, severity, and length-extension of coronary lesions in male patients undergoing coronary arteriography for clinically suspected coronary atherosclerosis. Arterioscler Thromb. 1994;14(11):1730-6. 28. Kral BG, Kalyani RR, Yanek LR, Vaidya D , Fishman EK, Becker DM, et al. Relation of plasma lipoprotein(a) to subclinical coronary plaque volumes, three-vessel and left main coronary disease, and severe coronary stenoses in apparently healthy African-Americans with a family history of early-onset coronary artery Disease. Am J Cardiol. 2016;118(5):656-61. 29. Onat A, Ozhan H, Can G, Hergenç G, Karabulut A, Albayrak S. Serum apolipoprotein B is superior to LDL-cholesterol level in predicting incident coronary disease among Turks. Anadolu Kardiyol Derg. 2007;7(2):128-33. 30. Liting P , Guoping L, Zhenyue C. Apolipoprotein B/apolipoprotein A1 ratio and non-high-density lipoprotein cholesterol. Predictive value for CHD severity and prognostic utility in CHDpatients. Herz. 2015;40(Suppl 1):1-7. 31. Song Y, Yang Y, Zhang J, Wang Y, He W, Zhang X, et al. The apoB100/apoAI ratio is independently associatedwith the severity of coronary heart disease: a cross sectional study in patients undergoing coronary angiography. Lipids Health Dis. 2015 Nov 18;14:150. 32. Shiiba M, Zhang B, Miura SI, Ike A, Nose D, Kuwano T, et al. Association between discordance of LDL-C and non-HDL-C and clinical outcomes in patients with stent implantation: from the FU-Registry. Heart Vessels. 2018;33(2):102-12. 475